VRTX- Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 72 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Activity
Buys and sells only
Transactions
10 filings · page 28
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2020 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sale+OE | 2,125 | $292.05 | $620,609.75 | -0.8% | |
| Jul 10, 2020 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 700 | $293.15 | $205,205.60 | -1.4% | |
| Jul 7, 2020 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale+OE | 2,786 | $300.00 | $835,800.00 | -7.3% | |
| Jun 30, 2020 | Leiden Jeffrey M47 | Executive Chairman | Sell | 32,792 | $286.15 | $9,383,303.77 | -28.3% | |
| Jun 2, 2020 | Bhatia Sangeeta N.48 | Director | Sell | 952 | $282.88 | $269,298.44 | -2.6% | |
| May 15, 2020 | Altshuler David48 | EVP, Global Research And CSO | Sell | 82 | $284.37 | $23,318.29 | - | |
| May 15, 2020 | Kewalramani Reshma55 | CEO &President | Sell | 99 | $284.17 | $28,132.46 | - | |
| May 15, 2020 | Tatsis Ourania48 | EVP, Chief Regulatory Officer | Sell | 120 | $284.00 | $34,080.09 | -0.1% | |
| May 15, 2020 | Silva Paul M | SVP &Controller | Sell | 151 | $284.00 | $42,884.58 | -0.1% | |
| May 15, 2020 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 58 | $284.41 | $16,495.71 | - |